Kimia Therapeutics

Developer of a drug discovery platform intended to cater to the areas of oncology, immunology, and inflammation. The company’s platform helps apply high throughput precision chemistry in combination with genome editing and machine learning to identify druggable sites at key nodes of intervention in human disease and to generate datasets that reveal the molecular features of active and inactive drug molecules and through machine learning generate algorithms and feature maps, helping clients accelerate the discovery of drugs for novel and challenging targets.